Shanghai Children's Health, Education and Lifestyle Evaluation, Preschool (the SCHEDULE-P Study)
Launched by SIJIA GU · Jul 28, 2019
Trial Information
Current as of May 14, 2025
Recruiting
Keywords
ClinConnect Summary
The SCHEDULE-P Study is a research project taking place in Shanghai that looks at how young children, specifically those aged 3 to 6, are developing during their early education years. The goal of this study is to understand how effective different early education methods are, which will help improve the educational services offered to children in Shanghai. Researchers will collect information through online questionnaires and in-person tests to see how children's development changes over time.
To be eligible for this study, children must be 3 years old and currently enrolled in either public or private kindergartens in Shanghai since 2016. However, children attending international kindergartens are not included in this research. If your child participates, you can expect to answer some questions and possibly take part in activities designed to measure their development. This study aims to provide valuable insights that could enhance early education for all children in the area.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All 3-year-old children entered into public kindergartens or private kindergartens in Shanghai since 2016.
- Exclusion Criteria:
- • Children entered into international kindergartens
About Sijia Gu
Sijia Gu is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on integrity and scientific rigor, Sijia Gu oversees the design, implementation, and management of clinical trials across various therapeutic areas. The organization emphasizes collaboration with healthcare professionals and regulatory bodies to ensure compliance with industry standards and ethical practices. Through a patient-centered approach, Sijia Gu aims to contribute to the development of safe and effective treatments, fostering progress in the healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials